Back to Trades
Wolf Myles
InsiderCIK 0001808317
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Wolf Myles has disclosed $54.7K in transactions — all concentrated in Akebia Therapeutics, Inc. (AKBA). Data is sourced from official SEC Form 3, 4, and 5 filings.